Peer Review History
| Original SubmissionJune 25, 2024 |
|---|
|
PONE-D-24-25871RecombiCraft Library construction: A novel method for DNA Library cloning and expansion using non-enzymatic single-step DNA recombination and liquid culturePLOS ONE Dear Dr. Harada, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 12 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Md Rajib Sharker, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: This project received financial support from two sources: the Elsa U. Pardee Foundation, which focuses on cancer research and treatment funding, and the Michigan Translational Research and Commercialization (MTRAC) program, which provides early-stage funding to promote the commercialization of innovative technologies. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments (if provided): The manuscript is well-organized and clearly written, presenting a study objective that is both relevant and valuable for publication. However, I strongly encourage the authors to address several critical issues within the manuscript. These concerns need to be thoroughly addressed to enhance the quality and rigor of the study. Therefore, I recommend that the manuscript undergo significant revisions before it can be considered for publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this study, the author presents a novel, rapid, and cost-effective method for constructing DNA libraries in E. coli. RecombiCraft combines seamless ligation cloning extract (SLiCE) with liquid culture amplification to minimize sequence biases. The method employs high-fidelity polymerase for the PCR synthesis of library backbones and inserts, and utilizes SLiCE for the assembly of DNA fragments, which are then introduced into E. coli via electroporation. RecombiCraft proves to be an economical and efficient tool, maintaining library uniformity and significantly shortening the library generation period, thus making it a valuable asset for genetic research and biotechnological applications. The manuscript is well-organized and written, and the study's objective is worthy of publication. However, the reviewer strongly encourages the authors to address the following issues. Major amendments are required before the manuscript can be published. Constructive comments for revision are as follows: Major concern 1. The author introduces RecombiCraft as an "innovative, rapid, and cost-efficient method" but doesn't provide enough specific details on what makes it unique compared to existing methods. Adding data or results could strengthen the claim. Query 2: The manuscript would be significantly strengthened if you will do comet assay to check the DNA integrity after exposure and recovery of crude oil. Query 3: The quality of some figures is not adequate for publication. Query 4: In discussion section, rephrased some sentences for better readability and coherence. Query 5: Made the comparison between SLiCE cloning and traditional methods clearer and more concise. Minor comments: Line 27: The phrase "significantly shorter library generation period" is vague. Providing specific time comparisons with other methods would make this claim more impactful. Line 102: Library DNA" should either both be capitalized and not, depending on whether it's a proper noun. It might be better as "library DNA". Please check it throughout the manuscript. Line 116-117: The sentence "To optimize library cloning, we created homologous sequences of varying lengths and compared their cloning efficiency." could be simplified or rephrased for clarity. Line 149-151: Please omit correct the sentence in following ways. The monobody library was designed based on a hydrophilic variant of human fibronectin, which improves biodistribution properties, making it well-suited for downstream applications in molecular imaging and therapeutics days post fertilization as you mentioned it before. Line 152: The term "throughout" is omitted, which makes the sentence slightly redundant. Correct the sentence in following ways. This hydrophilic monobody library included diverse amino acid sequences in three solvent-exposed binding loops, akin to antibody CDR-H1/2/3, while conserving amino acids in the framework positions. Line 159: The phrase "at least backbone" is confusing and seems incorrect. Line 164-165: he phrase "not only... but also" suggests two parallel ideas, but the way it's phrased here makes it slightly unclear. Correct the sentence in following ways. This optimized construction method confirmed the absence of unwanted sequences and validated the structural integrity and diversity of the monobody library. Line 172: Used "host cells" instead of "suitable cells" for clarity and consistency. Line 192: Replaced "however" with a semicolon to improve readability and flow. Line 198: Used "may" instead of "might" for a more formal tone and added "generally" to clarify that the correlation is not absolute. Line 220-223: Changed "named RecombiCraft" to "which we have named RecombiCraft" for clarity. Changed "enables acquisition of sufficient DNA quantities" to "facilitates the acquisition of sufficient DNA quantities" for smoother readability. Changed "fine-tuning" to "optimizing" for a more formal tone and clearer meaning. Reviewer #2: General comments of the manuscript: The manuscript entitled, “RecombiCraft Library construction: A novel method for DNA Library cloning and expansion using non-enzymatic single-step DNA recombination and liquid culture”, is completely novel in biotechnology for sustainable development and wellbeing of the shorter library generation period. From the reviewer observation this research manuscript can be accepted with minor corrections in the esteemed journal, “PlosOne”. The following correction is given below: The first figure requires high resolution since it seem a fuzzy like image to the reviewer. 1) Introduction: Accepted 2) Materials and methods: Accepted 3) Results: Accepted 4) Discussion: Accepted 5) Conclusion: Accepted ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
RecombiCraft library construction: A novel method for DNA library cloning and expansion using non-enzymatic single-step DNA recombination and liquid culture PONE-D-24-25871R1 Dear Dr. Harada We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Md Rajib Sharker, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): The authors did adequately address all the queries raised by Reviewer in their revised manuscript. The paper can now be considered for publication |
| Formally Accepted |
|
PONE-D-24-25871R1 PLOS ONE Dear Dr. Harada, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Md Rajib Sharker Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .